Integrated Workflow for the Digital Review of FISH Images in the Laboratory Image Management System
Results show over 99% correlation between dedicated FISH analysis and IMS review, supporting reliable integration of FISH images into digital pathology workflows.
Digital Linked Visualization of H&E and Immunofluorescence WSI in Dermatopathology – a Pilot Evaluation
The study demonstrates high concordance between digital and manual assessments, highlighting the potential of combined H&E and IF WSI review to improve diagnostic insight and efficiency.
Multicenter pilot evaluation of a new AI-based metaphase finder for application in karyotyping peripheral blood and bone marrow specimens
This multicenter pilot study assesses a new AI-based metaphase finder designed to improve detection during slide scanning. The results demonstrate increased metaphase identification and reduced capture of non-metaphase material, enhancing efficiency in karyotyping workflows.
Comparative evaluation of an AI-based scanner-agnostic add-on utility versus conventional karyotyping software
This study evaluates an AI-based scanner-agnostic add-on for automated karyotyping that integrates with existing imaging systems. Results show a significant reduction in metaphase analysis time, supporting faster and more efficient cytogenetic workflows.
Automated Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Carcinoma Using Deep Learning on Pretreatment Core Needle Biopsy Samples
A new breast cancer study demonstrates how ASI’s HiPath Pro platform support AI-driven predictive oncology through high-quality digital pathology imaging.
Agreement analysis between manual and computational scoring of Ki-67 in breast cancer
ASI’s second abstract presented at ECP 2025 demonstrates strong agreement between manual and computational scoring of Ki-67 in breast cancer. The study validates ASI’s AI-powered quantification tools as a reliable complement to routine pathology assessment.
Computer-aided scoring as an objective method in the assessment of HER2 immunostaining in breast cancer with high intra-tumoral heterogeneity
This study shows that computer-aided scoring provides a reliable and reproducible method for assessing HER2 immunostaining in breast cancer with high intra-tumoral heterogeneity.
Fragile X Karyotyping A Cytogenetic Perspective
In recognition of Autism Awareness Month, join us for a special webinar featuring Brenda Buthelezi from Lancet Laboratories, Johannesburg, South Africa. Discover groundbreaking insights into Fragile X Karyotyping, its challenges, and how ASI’s advanced system enhances cytogenetic analysis.
Use of Artificial Intelligence to Enhance Karyotyping Efficiency of Both Normal and Abnormal Cases
Mendel Laboratories in Mexico used ASI’s HiBand system to demonstrate the efficiency gains of AI-powered karyotyping – significantly reducing analysis time for the analysis of both normal and abnormal cases.
New Q-Band Artificial Intelligence – Based Chromosome Analysis and Karyotyping – a Pilot Evaluation
Discover ASI’s new AI-powered Q-banded karyotyping solution, delivering high accuracy and fewer manual corrections. This innovation streamlines cytogenetic workflows for faster, more efficient chromosome analysis.
ASI has officially joined the ZYTOMICS family
By combining ASI’s imaging and analysis solutions with ZYTOMICS’ reagents, automation and analytics, the companies aim at creating more integrated and scalable solutions for pathology and cytogenetics laboratories.
From Manual To Digital Fluorescence In Situ Hybridization (FISH) – A Time Saving Experience
A joint study by Soroka Medical Center and Applied Spectral Imaging shows that digital FISH using ASI’s HiFISH platform significantly reduces analysis time – by 40% – compared to manual methods.